Please login to the form below

Alexandre Lebeaut

This page shows the latest Alexandre Lebeaut news and features for those working in and with pharma, biotech and healthcare.

Cabometyx on track for new liver cancer indication

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Dr Sotirios Stergiopoulos leaves Shire for Ipsen

His new role will see him report to Alexandre Lebeaut, executive vice-president R&D and chief scientific officer of Ipsen, who said: “Stergiopoulos has extensive experience in directing global medical
Ipsen appoints executive vice president

Alexandre Lebeaut also set to be chief scientific officer. Ipsen has appointed Dr Alexandre Lebeaut as its new executive VP, research and development, and chief scientific officer to focus on the ... During his four years at Ipsen, Dr Lebeaut has been
Ipsen boosts specialty care and R&D leadership teams

Meanwhile, Dr Stergiopoulos (pictured left) has been appointed as senior vice president and head of global medical affairs, reporting to R&D lead Dr Alexandre Lebeaut. ... Dr Lebeaut said: “Sotirios brings extensive experience in directing global
Ipsen’s chief scientific officer steps down

Dr Claude Bertrand will be replaced ad interim by Alexandre Lebeaut. ... He will be replaced by Dr Alexandre Lebeaut as interim head of research and development while the firm searches for a permanent successor.